Business Description
Vita Life Sciences Ltd
NAICS : 325412
SIC : 2834
ISIN : AU000000VLS8
Description
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region. The company has four reportable segments which include The Australia segment comprises of sale of Herbs of Gold range in Australia and exports into China. The Singapore and Malaysia segment, comprise of Vitahealth and Herbs of Gold range in both countries The other market segment comprises of Vitahealth ranges.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 64.53 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Interest Coverage | 53.15 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 6.41 | |||||
| Beneish M-Score | -2.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.4 | |||||
| 3-Year EBITDA Growth Rate | 12.2 | |||||
| 3-Year EPS without NRI Growth Rate | 12.7 | |||||
| 3-Year FCF Growth Rate | 16.6 | |||||
| 3-Year Book Growth Rate | 18.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.06 | |||||
| 9-Day RSI | 46.2 | |||||
| 14-Day RSI | 42.53 | |||||
| 6-1 Month Momentum % | -9.96 | |||||
| 12-1 Month Momentum % | 16.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.96 | |||||
| Quick Ratio | 2.18 | |||||
| Cash Ratio | 1.46 | |||||
| Days Inventory | 145.65 | |||||
| Days Sales Outstanding | 51.65 | |||||
| Days Payable | 100.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.05 | |||||
| Dividend Payout Ratio | 0.53 | |||||
| 3-Year Dividend Growth Rate | 18.4 | |||||
| Forward Dividend Yield % | 3.72 | |||||
| 5-Year Yield-on-Cost % | 8.98 | |||||
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | 2.03 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.48 | |||||
| Operating Margin % | 15.36 | |||||
| Net Margin % | 11.92 | |||||
| FCF Margin % | 13.29 | |||||
| ROE % | 21.47 | |||||
| ROA % | 15.51 | |||||
| ROIC % | 33 | |||||
| ROC (Joel Greenblatt) % | 72.95 | |||||
| ROCE % | 29.98 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.2 | |||||
| PE Ratio without NRI | 11.2 | |||||
| Shiller PE Ratio | 16.98 | |||||
| Price-to-Owner-Earnings | 11.26 | |||||
| PEG Ratio | 0.46 | |||||
| PS Ratio | 1.33 | |||||
| PB Ratio | 2.21 | |||||
| Price-to-Tangible-Book | 2.16 | |||||
| Price-to-Free-Cash-Flow | 10.03 | |||||
| Price-to-Operating-Cash-Flow | 9.48 | |||||
| EV-to-EBIT | 5.89 | |||||
| EV-to-EBITDA | 5.67 | |||||
| EV-to-Revenue | 0.98 | |||||
| EV-to-FCF | 7.6 | |||||
| Price-to-Projected-FCF | 0.92 | |||||
| Price-to-Median-PS-Value | 0.97 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.47 | |||||
| Price-to-Graham-Number | 1.03 | |||||
| Price-to-Net-Current-Asset-Value | 2.85 | |||||
| Price-to-Net-Cash | 12.53 | |||||
| Earnings Yield (Greenblatt) % | 16.99 | |||||
| FCF Yield % | 9.98 | |||||
| Forward Rate of Return (Yacktman) % | 25.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vita Life Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 78.919 | ||
| EPS (TTM) (A$) | 0.171 | ||
| Beta | 0.75 | ||
| Volatility % | 26.21 | ||
| 14-Day RSI | 42.53 | ||
| 14-Day ATR (A$) | 0.050453 | ||
| 20-Day SMA (A$) | 1.928 | ||
| 12-1 Month Momentum % | 16.85 | ||
| 52-Week Range (A$) | 1.73 - 2.5 | ||
| Shares Outstanding (Mil) | 55.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vita Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vita Life Sciences Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vita Life Sciences Ltd Frequently Asked Questions
What is Vita Life Sciences Ltd(ASX:VLS)'s stock price today?
The current price of ASX:VLS is A$1.88. The 52 week high of ASX:VLS is A$2.50 and 52 week low is A$1.73.
When is next earnings date of Vita Life Sciences Ltd(ASX:VLS)?
The next earnings date of Vita Life Sciences Ltd(ASX:VLS) is .
Does Vita Life Sciences Ltd(ASX:VLS) pay dividends? If so, how much?
The Dividend Yield %  of Vita Life Sciences Ltd(ASX:VLS) is 5.05% (As of Today), Highest Dividend Payout Ratio of Vita Life Sciences Ltd(ASX:VLS) was 0.86. The lowest was 0.27. And the median was 0.45. The  Forward Dividend Yield % of Vita Life Sciences Ltd(ASX:VLS) is 3.72%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers